Single Ascending Dose Study of PRT064445, a Factor Xa (fXa) Inhibitor Antidote

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
This is a single center, double-blind, randomized, placebo-controlled, ascending, single dose study of PRT064445 or its matching placebo, in healthy subjects.
Epistemonikos ID: d11a1ea6388caee101be0f7e5a8d2aa95eb6cf5a
First added on: May 20, 2024